TREM2 and breast carcinoma: found that in a CNS tumor model, intracranial injection of the EO771 breast cancer cell line into mice resulted in accelerated tumor growth and reduced survival rates in Trem2−/− mice, further confirming the antitumor role of TREM2 in CNS tumors.